Phase I Study on Safety and Pharmacokinetics of a Novel Influenza Endonuclease Inhibitor, AL-794 (JNJ-64155806), following Single- and Multiple-Ascending doses in Healthy Adults
暂无分享,去创建一个
P. V. Remoortere | J. Symons | T. Kakuda | M. Boyce | S. Chanda | J. Yogaratnam | J. Rito | T. Mitchell | Kusum Gupta | J. Fry